NYSEARCA:MYO - NYSE Arca - US62857J2015 - Common Stock - Currency: USD
NYSEARCA:MYO (2/20/2025, 1:24:37 PM)
5.91
-0.13 (-2.15%)
The current stock price of MYO is 5.91 USD. In the past month the price increased by 0.83%. In the past year, price increased by 111.19%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 28.47 | 230.59B | ||
ISRG | INTUITIVE SURGICAL INC | 82.23 | 214.98B | ||
BSX | BOSTON SCIENTIFIC CORP | 41.76 | 154.50B | ||
SYK | STRYKER CORP | 31.57 | 146.69B | ||
MDT | MEDTRONIC PLC | 16.37 | 112.12B | ||
BDX | BECTON DICKINSON AND CO | 16.27 | 65.00B | ||
EW | EDWARDS LIFESCIENCES CORP | 28.48 | 44.01B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 20.44 | 41.94B | ||
IDXX | IDEXX LABORATORIES INC | 40.2 | 37.03B | ||
DXCM | DEXCOM INC | 53.84 | 34.70B | ||
RMD | RESMED INC | 26.3 | 34.15B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 17.15 | 23.38B |
Myomo, Inc. is a wearable medical robotics company, which engages in the business of developing, designing, and producing myoelectric orthotics for people with neuromuscular disorders. The company is headquartered in Boston, Massachusetts and currently employs 101 full-time employees. The company went IPO on 2017-06-12. The company develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm, and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. The company provides devices directly to patients and bill their insurance companies directly. The company also sells its products through various other sales channels, including through orthotics and prosthetics providers, the veteran’s administration, and others.
MYOMO INC
137 Portland Street, 4th Floor
Boston MASSACHUSETTS 02114 US
CEO: Paul R. Gudonis
Employees: 104
Company Website: https://myomo.com/
Investor Relations: http://ir.myomo.com
Phone: 16179969058
The current stock price of MYO is 5.91 USD. The price decreased by -2.15% in the last trading session.
The exchange symbol of MYOMO INC is MYO and it is listed on the NYSE Arca exchange.
MYO stock is listed on the NYSE Arca exchange.
10 analysts have analysed MYO and the average price target is 7.82 USD. This implies a price increase of 32.32% is expected in the next year compared to the current price of 5.91. Check the MYOMO INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
MYOMO INC (MYO) has a market capitalization of 199.11M USD. This makes MYO a Micro Cap stock.
MYOMO INC (MYO) currently has 104 employees.
MYOMO INC (MYO) has a support level at 6.02 and a resistance level at 6.07. Check the full technical report for a detailed analysis of MYO support and resistance levels.
The Revenue of MYOMO INC (MYO) is expected to grow by 56.52% in the next year. Check the estimates tab for more information on the MYO EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
MYO does not pay a dividend.
MYOMO INC (MYO) will report earnings on 2025-03-06, after the market close.
MYOMO INC (MYO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.23).
The outstanding short interest for MYOMO INC (MYO) is 2.43% of its float. Check the ownership tab for more information on the MYO short interest.
ChartMill assigns a technical rating of 10 / 10 to MYO. When comparing the yearly performance of all stocks, MYO is one of the better performing stocks in the market, outperforming 95.14% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to MYO. MYO has a great financial health rating, but its profitability evaluates not so good.
Over the last trailing twelve months MYO reported a non-GAAP Earnings per Share(EPS) of -0.23. The EPS increased by 54% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -57.5% | ||
ROE | -93.26% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 80% to MYO. The Buy consensus is the average rating of analysts ratings from 10 analysts.
For the next year, analysts expect an EPS growth of 37.96% and a revenue growth 56.52% for MYO